| scholarly article | Q13442814 |
| P2093 | author name string | Z Wang | |
| M Bar-Eli | |||
| M Ruiz | |||
| O Nyormoi | |||
| D Doan | |||
| D McConkey | |||
| P2860 | cites work | Genomic structure and DNA binding properties of the human zinc finger transcriptional repressor AP-2rep (KLF12) | Q22253285 |
| An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2 | Q24308857 | ||
| Cloning and characterization of a second AP-2 transcription factor: AP-2 beta | Q24309166 | ||
| Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression | Q24310632 | ||
| RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. | Q24522518 | ||
| Caspases: the executioners of apoptosis | Q24530218 | ||
| Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor | Q24554732 | ||
| Transcriptional activation by Myc is under negative control by the transcription factor AP-2 | Q24568331 | ||
| Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis | Q24647389 | ||
| Lamin proteolysis facilitates nuclear events during apoptosis | Q24681695 | ||
| Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis | Q24683768 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| The N-end rule pathway controls the import of peptides through degradation of a transcriptional repressor | Q27933631 | ||
| Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors | Q28116721 | ||
| Mammalian caspases: structure, activation, substrates, and functions during apoptosis | Q28139429 | ||
| TNF-induced signaling in apoptosis | Q28142549 | ||
| Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2 | Q28144968 | ||
| Analysis of the DNA-binding and activation properties of the human transcription factor AP-2 | Q28271397 | ||
| Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis | Q28296478 | ||
| Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis | Q28369400 | ||
| Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation | Q28379199 | ||
| Transcription factor AP-2 essential for cranial closure and craniofacial development | Q28513302 | ||
| Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta | Q28591284 | ||
| Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 | Q28594321 | ||
| Cleavage of focal adhesion kinase by caspases during apoptosis | Q28610850 | ||
| Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis | Q29614983 | ||
| A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis | Q29617776 | ||
| Caspase and calpain substrates: roles in synaptic plasticity and cell death | Q33734817 | ||
| The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6 and -7 during TGEV-induced apoptosis | Q33803124 | ||
| Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies | Q33835849 | ||
| Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. | Q33853003 | ||
| Role of AP-2 in tumor growth and metastasis of human melanoma | Q33865634 | ||
| Coactivator PC4 mediates AP-2 transcriptional activity and suppresses ras-induced transformation dependent on AP-2 transcriptional interference | Q33957311 | ||
| Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen | Q34163571 | ||
| Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements | Q34164797 | ||
| The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma | Q34725896 | ||
| Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter | Q34929338 | ||
| Developmental regulation of transcription factor AP-2 duringXenopus laevisembryogenesis | Q35770598 | ||
| p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis | Q36641213 | ||
| Alternative mRNAs encode multiple isoforms of transcription factor AP-2 during murine embryogenesis. | Q36703622 | ||
| Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene | Q37045364 | ||
| The site of cAMP action in the insulin induction of gene expression of acetyl-CoA carboxylase is AP-2. | Q38316793 | ||
| STAT1 is inactivated by a caspase | Q38337795 | ||
| Proteolytic cleavage of the mdm2 oncoprotein during apoptosis | Q38343171 | ||
| High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax. | Q38361617 | ||
| Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer | Q38466179 | ||
| PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. | Q39727130 | ||
| A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines | Q40873102 | ||
| Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately | Q40922480 | ||
| Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis | Q40963135 | ||
| Phenylethanolamine N-methyltransferase gene expression: synergistic activation by Egr-1, AP-2 and the glucocorticoid receptor | Q40998289 | ||
| Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro | Q41075568 | ||
| Programming gene expression in developing epidermis | Q42476595 | ||
| Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. | Q43554604 | ||
| Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. | Q44314802 | ||
| Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. | Q45345476 | ||
| AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression | Q45345486 | ||
| Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. | Q46001099 | ||
| Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells | Q47954377 | ||
| AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells | Q48063172 | ||
| Proteolytic cleavage of beta-catenin by caspases: an in vitro analysis | Q49170064 | ||
| Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. | Q50857224 | ||
| A novel alternative spliced variant of the transcription factor AP2alpha is expressed in the murine ocular lens. | Q52183893 | ||
| Chicken transcription factor AP-2: cloning, expression and its role in outgrowth of facial prominences and limb buds. | Q52192985 | ||
| The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. | Q52573380 | ||
| N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. | Q53472029 | ||
| Characterization of Caspase Processing and Activation in HL-60 Cell Cytosol Under Cell-free Conditions | Q58289992 | ||
| Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 | Q59341249 | ||
| Apoptosis induced by the nuclear death domain protein p84N5 is associated with caspase-6 and NF-kappa B activation | Q64380730 | ||
| Redox modulation of AP-2 DNA binding activity in vitro. | Q64993609 | ||
| Proteolytic activity in amyotrophic lateral sclerosis IgG preparations | Q71864942 | ||
| Substrate specificities of caspase family proteases | Q73201753 | ||
| Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1) | Q73283365 | ||
| Molecular mechanisms of melanoma metastasis | Q73868474 | ||
| CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB | Q74309691 | ||
| Transcription factor AP-2 mRNA and DNA binding activity are constitutively expressed in SV40-immortalized but not normal human lung fibroblasts | Q77222701 | ||
| CREB and its associated proteins act as survival factors for human melanoma cells | Q77229224 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 4856-67 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells | |
| P478 | volume | 21 |
| Q28742161 | A quantitative method for the specific assessment of caspase-6 activity in cell culture |
| Q24676129 | AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells |
| Q36748207 | Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review |
| Q44427674 | An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells |
| Q37308327 | Caspase 6 regulates B cell activation and differentiation into plasma cells |
| Q44179114 | Caspase cleavage of the transcription factor FLI-1 during preB leukemic cell death. |
| Q24537579 | Caspase processing and nuclear export of CTP:phosphocholine cytidylyltransferase alpha during farnesol-induced apoptosis |
| Q39647076 | Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation |
| Q33883801 | Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines. |
| Q42812731 | Caspase-mediated degradation of PPARgamma proteins in adipocytes |
| Q40748909 | Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth |
| Q35013020 | Effector caspases and leukemia |
| Q35050463 | Expression and activation of caspase-6 in human fetal and adult tissues |
| Q47596125 | Expression of AP‐2α, c‐kit, and cleaved caspase‐6 and ‐3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression? |
| Q35091412 | Many cuts to ruin: a comprehensive update of caspase substrates |
| Q28567405 | Oxidative repression of NHE1 gene expression involves iron-mediated caspase activity |
| Q40403841 | Posttranscriptional control of aquaporin-2 abundance by vasopressin in renal collecting duct principal cells |
| Q37256980 | Regulation of B-cell entry into the cell cycle |
| Q36818158 | Targets of caspase-6 activity in human neurons and Alzheimer disease |
| Q21184171 | The AP-2 family of transcription factors |
| Q33492610 | The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis |
| Q35173065 | Therapeutic approaches to bladder cancer: identifying targets and mechanisms |
| Q53554762 | pC6-2/caspase-6 system to purify glutathione-S-transferase-free recombinant fusion proteins expressed in Escherichia coli. |
Search more.